BioT Overview
BioT's PaaS relieves HealthTech developers of the burden of meeting regulatory requirements, allowing them to focus entirely on medical AI innovation, where the rest of the HealthTech solution is delivered by simple NoCode / LowCode. BioT supports the health of over 100,000 patients who use BioT-powered clouds by dozens of medical device companies, from very large enterprises to startups.
Cumulative Funding Raised Over Time ($)
$6.9MJun 2021
Latest News
growth-positive
Medcrypt Expands Strategic Partnerships with BioT to Enhance Cybersecurity in Medical Devices
Medcrypt, a leader in medical device cybersecurity, has expanded its strategic partnerships with BioT, Extra Security, RTI, and Stratigos Security. These collaborations aim to enhance cybersecurity solutions for medical devices, focusing on cryptography, vulnerability management, and FDA compliance. The partnerships address the growing demand for secure, interoperable technology in the healthcare industry. Medcrypts network will provide comprehensive protection across device connectivity, threat detection, and regulatory alignment. The company has raised over $36 million in funding, with contributions from Johnson & Johnson Innovations, Intuitive Ventures, and Dexcom Ventures. Medcrypts efforts are geared towards ensuring medical devices are secure by design, expediting the go-to-market process for new technologies.
PartnersInvestment
growth-positive
ATDev and BioT Medical Transform Physical Therapy Through Advanced Remote Care and Assistive Technology
ATDev, a leader in assistive technology, has announced a strategic partnership with BioT Medical at the ACRM 100th Annual Conference. This collaboration aims to redefine orthopedic rehabilitation by integrating ATDevs exoskeleton technologies with BioTs advanced remote care capabilities. The partnership will enhance patient outcomes by enabling real-time monitoring and immediate interventions. BioTs platform will support ATDevs operations by streamlining data collection, improving device functionality, and ensuring regulatory compliance. This alliance is expected to accelerate ATDevs market entry and enhance their remote care offerings, setting a new standard in patient care.
Partners
growth-positive
Sendance Partners with BioT to Revolutionize Sensor Grids for Health Tech | Sports
Sendance, a company specializing in advanced sensor grid solutions, has announced a partnership with BioT, a provider of cloud infrastructure for medtech and healthtech applications. This collaboration aims to leverage BioTs secure and scalable cloud platform to enhance Sendances capabilities in the health tech and sports markets. The partnership is expected to accelerate innovation, improve security and compliance, and streamline operations for Sendance. By utilizing BioTs platform, Sendance can focus on developing smart wearable technologies that integrate seamlessly into various materials, offering advanced data collection and monitoring functionalities. This strategic alliance is poised to expand Sendances market reach and expedite the development of new products.
Partners
growth-positive
BioT Medical Awarded 2023 AWS Rising Star Partner of the Year
BioT Medical has been recognized as the Rising Star Partner of the Year in the 2023 Geo and Global AWS Partner Awards. This accolade highlights the companys significant growth and innovation in developing solutions on Amazon Web Services (AWS). The award was announced during the AWS re:Invent 2023 event. BioT Medicals CEO, Daniel Adler, expressed pride in the achievement, attributing it to the teams dedication to excellence and their successful collaboration with AWS. The companys cloud-based platform for medical devices is noted for its self-service, open, regulated, and no-code approach, which facilitates rapid deployment and regulatory compliance. This recognition underscores BioT Medicals commitment to advancing healthcare technology through AWS.
Partners
growth-positive
BioT Cloud-Native Medical Devices on AWS Marketplace | Scalable Solutions for Connected Care
BioT, a platform for building cloud-native medical devices, announced its availability on AWS Marketplace on July 7, 2023. This move strengthens BioTs 7-year partnership with AWS and enhances its existing certifications, including the AWS Foundational Technical Review Certification and AWS ISV Accelerate Program Status. By leveraging AWS, BioT aims to provide MedTech customers with a seamless way to develop connected medical device systems, addressing technical complexities, compliance, and cybersecurity challenges. The collaboration is expected to empower clients with scalability, cost-efficiency, and faster time-to-market for next-generation medical devices. BioTs platform is designed to meet the rigorous requirements of the medical device industry, offering a self-service PaaS tailored to the unique needs of MedTech firms.
Partners
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | $8.76M |
| Last funding | $1.1M |
| Stage | Seed |
| Rounds | 4 |
| Investors | 3 |
Team Members
7
Employees: 11-50
Web & Social Links
| Website | www.biot-med.com |
| Careers | Careers page |
Locations
Granit St 2, Petah Tikva, Israel
1313 Washington Street, Boston, MA, USA
Photos & Videos
3 item(s)
BioT Business
Business models
B2B
Product stage
Released
Employees
11-50
Sector
Health Tech & Life SciencesMedical DevicesDigital HealthcareCyber SecurityData SecurityCloud SecurityTarget Customer
Healthcare & Life SciencesLife SciencesPharmaceuticalsMedical Devices IndustryMedical ProductsMedical EquipmentHealthcareInsurance CompaniesProvidersCore Technology
Platforms & InterfacesPlug-inAPISoftwareArtificial IntelligenceGenerative AIChatbotsDeep LearningMachine LearningCommunicationsIOTData StorageCloudTags (29)
data-analyticscompliancemedical-device-manufacturersreal-timecloud-platformdigital-healthcaremobile-applicationsmhealthremote-monitoringiot-platformemrtelemedicinepharma-companiesserversdata-managementpatient-caretelehealthhealthcare-itsoftware-developmentmedical-devicesdiagnosticsartificial-intelligenceclinical-workflowmonitoringtreatmentspatient-engagementcloudmedical-technologiesclinical-trialsSolutions
{"title":"Healthcare / Medical Devices","description":"BioT's 'Regulated AI in the Cloud' solution provides a compliant and secure cloud platform for medical device companies to develop, deploy, and manage AI models, ensuring adherence to healthcare regulations while accelerating innovation and data utilization.","items":[{"name":"Revenue Growth","value":3,"titleTooltip":"Revenue Growth & Profitability","meterTooltip":{"title":"Substantial / Core","content":"Clear, significant contribution; broad, tangible gains."}},{"name":"Operational Efficiency","value":3,"titleTooltip":"Operational Excellence & Efficiency","meterTooltip":{"title":"Substantial / Core","content":"Clear, significant contribution; broad, tangible gains."}},{"name":"Customer Acquisition","value":3,"titleTooltip":"Customer Acquisition, Satisfaction & Loyalty","meterTooltip":{"title":"Substantial / Core","content":"Clear, significant contribution; broad, tangible gains."}},{"name":"Risk Mitigation","value":4,"titleTooltip":"Risk Mitigation & Business Resilience","meterTooltip":{"title":"Transformative / Strategic","content":"Fundamental, high-value enhancement with far-reaching strategic importance."}},{"name":"Talent Development","value":2,"titleTooltip":"Talent Development & Employee Empowerment","meterTooltip":{"title":"Marginal / Localized","content":"Small, isolated improvement; measurable but not substantial."}},{"name":"Agility & Innovation","value":4,"titleTooltip":"Strategic Agility & Innovation","meterTooltip":{"title":"Transformative / Strategic","content":"Fundamental, high-value enhancement with far-reaching strategic importance."}}]}
{"title":"Medical Devices","description":"BioT's \"Regulatory Aware Analytics\" provides a platform for medical device companies to streamline international regulatory compliance, accelerate market entry, optimize device performance, and enhance post-market surveillance through data-driven insights.","items":[{"name":"Revenue Growth","value":3,"titleTooltip":"Revenue Growth & Profitability","meterTooltip":{"title":"Substantial / Core","content":"Clear, significant contribution; broad, tangible gains."}},{"name":"Operational Efficiency","value":4,"titleTooltip":"Operational Excellence & Efficiency","meterTooltip":{"title":"Transformative / Strategic","content":"Fundamental, high-value enhancement with far-reaching strategic importance."}},{"name":"Customer Acquisition","value":2,"titleTooltip":"Customer Acquisition, Satisfaction & Loyalty","meterTooltip":{"title":"Marginal / Localized","content":"Small, isolated improvement; measurable but not substantial."}},{"name":"Risk Mitigation","value":5,"titleTooltip":"Risk Mitigation & Business Resilience","meterTooltip":{"title":"Disruptive / Paradigm-Shifting","content":"Revolutionary, industry-leading change that sets new benchmarks and norms."}},{"name":"Talent Development","value":1,"titleTooltip":"Talent Development & Employee Empowerment","meterTooltip":{"title":"Negligible / Incidental","content":"No discernible or only trivial positive effect; status-quo unchanged."}},{"name":"Agility & Innovation","value":4,"titleTooltip":"Strategic Agility & Innovation","meterTooltip":{"title":"Transformative / Strategic","content":"Fundamental, high-value enhancement with far-reaching strategic importance."}}]}
{"title":"Healthcare / Medical Devices","description":"BioT's Real-World Data (RWD) solution enables medical device companies to collect, manage, and analyze data from connected devices, integrating with EHR/EMR systems. It provides insights for clinical trials, post-market surveillance, personalized medicine, and regulatory compliance, ensuring data quality, security, and adherence to regulations like HIPAA and GDPR.","items":[{"name":"Revenue Growth","value":4,"titleTooltip":"Revenue Growth & Profitability","meterTooltip":{"title":"Transformative / Strategic","content":"Fundamental, high-value enhancement with far-reaching strategic importance."}},{"name":"Operational Efficiency","value":4,"titleTooltip":"Operational Excellence & Efficiency","meterTooltip":{"title":"Transformative / Strategic","content":"Fundamental, high-value enhancement with far-reaching strategic importance."}},{"name":"Customer Acquisition","value":4,"titleTooltip":"Customer Acquisition, Satisfaction & Loyalty","meterTooltip":{"title":"Transformative / Strategic","content":"Fundamental, high-value enhancement with far-reaching strategic importance."}},{"name":"Risk Mitigation","value":5,"titleTooltip":"Risk Mitigation & Business Resilience","meterTooltip":{"title":"Disruptive / Paradigm-Shifting","content":"Revolutionary, industry-leading change that sets new benchmarks and norms."}},{"name":"Talent Development","value":3,"titleTooltip":"Talent Development & Employee Empowerment","meterTooltip":{"title":"Substantial / Core","content":"Clear, significant contribution; broad, tangible gains."}},{"name":"Agility & Innovation","value":5,"titleTooltip":"Strategic Agility & Innovation","meterTooltip":{"title":"Disruptive / Paradigm-Shifting","content":"Revolutionary, industry-leading change that sets new benchmarks and norms."}}]}
Use Cases
Regulated AI in the CloudRegulatory Aware AnalyticsReal World DataGeographic Markets
Northern EuropeJapanWestern EuropeSouthern EuropeNew ZealandNorth AmericaIndiaAustraliaSingaporeBioT Financials
$8.76M
Total funding
Undisclosed
Capital raised
$1.1M
Last funding
Seed
Funding stage
4
Total rounds
3
Investors
Cumulative Funding Raised Over Time ($)
$6.9MJun 2021
Private Equity Funding
Seed
Jun 2021
$6.9M
Bridges Israel (Lead)
,
XT Venture Capital, North First Ventures
Non-Equity Funding
GrantEvent
Jan 2022
$1.1M
Israel Innovation Authority
GrantEvent
Nov 2020
$700K
Israel Innovation Authority
GrantEvent
Sep 2019
$55K
EU Horizon 2020
BioT Lifecycle
Cumulative Funding Raised Over Time
$6.9MJun 2021
All Events
Seed
Jun 2021
$6.9M
Bridges Israel (Lead)
,
XT Venture Capital, North First Ventures
GrantEvent
Jan 2022
$1.1M
Israel Innovation Authority
GrantEvent
Nov 2020
$700K
Israel Innovation Authority
GrantEvent
Sep 2019
$55K
EU Horizon 2020
BioT News
16 articles
growth-positive
Medcrypt Expands Strategic Partnerships with BioT to Enhance Cybersecurity in Medical Devices
Medcrypt, a leader in medical device cybersecurity, has expanded its strategic partnerships with BioT, Extra Security, RTI, and Stratigos Security. These collaborations aim to enhance cybersecurity solutions for medical devices, focusing on cryptography, vulnerability management, and FDA compliance. The partnerships address the growing demand for secure, interoperable technology in the healthcare industry. Medcrypts network will provide comprehensive protection across device connectivity, threat detection, and regulatory alignment. The company has raised over $36 million in funding, with contributions from Johnson & Johnson Innovations, Intuitive Ventures, and Dexcom Ventures. Medcrypts efforts are geared towards ensuring medical devices are secure by design, expediting the go-to-market process for new technologies.
PartnersInvestment
growth-positive
ATDev and BioT Medical Transform Physical Therapy Through Advanced Remote Care and Assistive Technology
ATDev, a leader in assistive technology, has announced a strategic partnership with BioT Medical at the ACRM 100th Annual Conference. This collaboration aims to redefine orthopedic rehabilitation by integrating ATDevs exoskeleton technologies with BioTs advanced remote care capabilities. The partnership will enhance patient outcomes by enabling real-time monitoring and immediate interventions. BioTs platform will support ATDevs operations by streamlining data collection, improving device functionality, and ensuring regulatory compliance. This alliance is expected to accelerate ATDevs market entry and enhance their remote care offerings, setting a new standard in patient care.
Partners
growth-positive
Sendance Partners with BioT to Revolutionize Sensor Grids for Health Tech | Sports
Sendance, a company specializing in advanced sensor grid solutions, has announced a partnership with BioT, a provider of cloud infrastructure for medtech and healthtech applications. This collaboration aims to leverage BioTs secure and scalable cloud platform to enhance Sendances capabilities in the health tech and sports markets. The partnership is expected to accelerate innovation, improve security and compliance, and streamline operations for Sendance. By utilizing BioTs platform, Sendance can focus on developing smart wearable technologies that integrate seamlessly into various materials, offering advanced data collection and monitoring functionalities. This strategic alliance is poised to expand Sendances market reach and expedite the development of new products.
Partners
growth-positive
BioT Medical Awarded 2023 AWS Rising Star Partner of the Year
BioT Medical has been recognized as the Rising Star Partner of the Year in the 2023 Geo and Global AWS Partner Awards. This accolade highlights the companys significant growth and innovation in developing solutions on Amazon Web Services (AWS). The award was announced during the AWS re:Invent 2023 event. BioT Medicals CEO, Daniel Adler, expressed pride in the achievement, attributing it to the teams dedication to excellence and their successful collaboration with AWS. The companys cloud-based platform for medical devices is noted for its self-service, open, regulated, and no-code approach, which facilitates rapid deployment and regulatory compliance. This recognition underscores BioT Medicals commitment to advancing healthcare technology through AWS.
Partners
growth-positive
BioT Cloud-Native Medical Devices on AWS Marketplace | Scalable Solutions for Connected Care
BioT, a platform for building cloud-native medical devices, announced its availability on AWS Marketplace on July 7, 2023. This move strengthens BioTs 7-year partnership with AWS and enhances its existing certifications, including the AWS Foundational Technical Review Certification and AWS ISV Accelerate Program Status. By leveraging AWS, BioT aims to provide MedTech customers with a seamless way to develop connected medical device systems, addressing technical complexities, compliance, and cybersecurity challenges. The collaboration is expected to empower clients with scalability, cost-efficiency, and faster time-to-market for next-generation medical devices. BioTs platform is designed to meet the rigorous requirements of the medical device industry, offering a self-service PaaS tailored to the unique needs of MedTech firms.
Partners
growth-positive
BioT Medical and NTT DATA Announce Strategic Agreement to make Hospital Care at Home a Reality
BioT Medical has announced a strategic agreement with NTT DATA, a digital business and IT services leader, to offer a comprehensive platform for in-home patient services. The partnership aims to overcome the challenges associated with Hospital at Home services by integrating NTT DATAs patient and provider experience capabilities with BioTs NoCode capabilities for managing medical devices. The platform allows for high-quality patient care, minimal burden to clinicians, and compliance with cyber, privacy, and quality regulations. The collaboration addresses the need for remote monitoring and management of medical devices in home settings. BioT is recognized for its ability to engage and maintain a wide array of FDA-certified devices. The partnership aims to accelerate the adoption of remote patient care and transform it into the new normal.
Partners
growth-positive
IRegained partners with BioT to bring remotely monitored rehabilitation to clinicians and their stroke survivor patients
IRegained and BioT have announced a strategic partnership to bring remote-monitored rehabilitation to stroke and traumatic brain injury survivors. IRegained has developed the MyHand™ System, a targeted hand-function rehabilitation system, while BioT provides a platform for building cloud-native medical devices. The partnership aims to enhance and accelerate rehabilitation success by leveraging clinically-validated protocols, engaging games, and remote monitoring capabilities. The MyHand™ system will be available in multiple countries, and the partnership will enable IRegained to explore novel pricing models. The partnership is expected to have a positive impact on the growth of both companies.
Partners
growth-positive
Reshaping connected care with the cloud-based platform for medical devices by BioT
Israeli company BioT has developed a connected care platform for medical device and pharma companies. The platform enables medical devices to be securely connected to a regulated cloud environment and supports patient collaboration and engagement workflows. BioTs customers include medical technology, medical device, and pharma companies, with implementation used worldwide. The companys main competition comes from companies that attempt to develop their own cloud connectivity solutions, but BioT emphasizes the importance of focusing on unique medical devices. BioT offers advantages such as quick market entry, reduced development costs, and a secured and regulated platform. The companys next mission is to enter the German and European markets, with a focus on Germany, France, and England. BioT is seeking partnerships and investment opportunities in Europe.
CustomersPartners
growth-positive
BioT Raises $6.5 Million in Seed Round to Accelerate the Connected Care Revolution
BioT, a market leader in medical devices cloud connectivity and remote care, has announced a $6.5 million Seed Round financing led by Bridges Israel, North First Ventures, and XT Hi-Tech. The funding will be used to expand the team, develop the next generation of the platform, and support the growing sales pipeline in the US and Europe. BioT also appointed Daniel Adler as its Chief Executive Officer. The company aims to disrupt Connected Care by offering a secure cloud platform for medical device providers to connect their devices and engage with patients remotely. With its low-code platform, BioT reduces the time and cost required to develop connected care solutions. The company invites IoMT innovators to leverage its platform to expedite time to market and reduce costs.
InvestmentExpand
growth-positive
מיזם PlayBeyondBio: מפתחת החיסון לקורונה משקיעה גם בסטארטאפים ישראלים
The first round of the PlayBeyondBio initiative has concluded, a fast-track program for Israeli digital health startups to become international companies. The program included collaborations between pharmaceutical giants and startups, including Timestamp, which helps track patient medication intake, and DocDok, which closely monitors patients with respiratory diseases. The first round of Play Beyond Bio included nine digital health startups selected from dozens of candidates. The startups received close guidance for six months to define the companys vision, identify potential markets, set marketing messages, and embed technology.
PartnersExpand
Growth-Positive
Information Security Is a Core Challenge for the IoT Medical Device Industry, Says Bio-T CEO
Bio-T, an Israel-based company that develops cloud-based software for managing IoT medical devices, has seen increased interest due to the Covid-19 pandemic. The software allows medical devices to perform computations and collect data directly on the cloud, reducing costs and time to market for developers, while also offering a secure tool that complies with strict regulations. Bio-Ts technology has attracted investors and clients, including Rafael Beyar, a former director-general and CEO of the Rambam Health Care Campus. The company has 20 paying customers and generates several million dollars in annual sales revenue.
CustomersInvestment
growth-positive
https://www.jpost.com/israel-news/jvp-pharma-giant-astrazeneca-mentor-israeli-health-start-ups-into-market-627852
Nine Israeli health tech start-ups have been selected to join the PlayBeyondBio program, a joint platform established by AstraZeneca and Jerusalem Venture Partners (JVP) to grow internationally disruptive digital health companies. The program aims to connect entrepreneurs, investors, and potential customers, and is in collaboration with Maccabitech Healthcare Research and Innovation Institute, Morris Kahn, the Sagol Fund, Shaare Zedek Medical Center, and Microsoft for Startups. The selected start-ups will receive mentoring and guidance from AstraZeneca and JVP, with a focus on developing breakthrough technologies in areas such as cancer, lung disease, cardiovascular disease, and metabolic disease. The program aims to promote Israels standing as a global leader in digital health.
PartnersInvestment
growth-positive
Vectorious & BioT - Amazon Web Services (AWS)
Vectorious Medical Technologies has developed the V-LAP system, a miniature, battery-free sensory device positioned in the hearts left atrium, to help manage congestive heart failure. The company partnered with BioT, a healthcare technology company and Advanced Tier Technology Partner in the AWS Partner Network, to address scalability and security requirements. The BioT platform, which runs on Amazon Elastic Compute Cloud (Amazon EC2) instances, enables fast, end-to-end connectivity for Internet of Things (IoT) devices and mobile apps, and meets HIPAA, GDPR, and other regulatory compliance requirements. Vectorious expects V-LAP to improve the lives of congestive heart failure patients worldwide.
Partners
Enabling medical device vendors to realize the potential of the data collectible by their devices bio-T Project Fact Sheet H2020 CORDIS European Commission
growth-positive
Medical IoT: fully realizing the potential of medical device data
The article features an interview with Guy Vinograd, CEO of bio-T Medical, discussing the digital health capabilities of the bio-T platform. The platform provides features for patients, care givers, study nurses, payers, system administrators, technicians, and more. It focuses on consent management, adherence prediction, regulation authorization control, adherence tracking, patient recovery management, patient questionnaires, and clinical trial data governance. The platform also satisfies regulation-related digital health features such as medical-grade quality software, data privacy architecture, and cyber security. The article highlights the importance of connectivity for real-time usage tracking and compares actual usage to prescribed schedules. The bio-T platform is guided by FDAs cyber security guidelines and complies with HIPAA, GDPR, and other emerging guidelines.
CustomersPartners
growth-positive
Medical Device IoT - 10 Benefits - Part 3
The article discusses the benefits of IoMT (Internet of Medical Things) in healthcare. It highlights the impact of cloud connectivity on predictive maintenance, better license control, TCO reduction, and protecting intellectual property. The use of cloud connectivity allows devices to report usage and predict when replacements are needed. It also enables easy license control and the ability to generate recurring revenues through subscription-based models. IoMT significantly reduces TCO by utilizing mobile phones and cloud computing. Additionally, it provides an opportunity to protect intellectual property by moving logic and algorithms to the cloud. The article is dated December 20, 2017.
CustomersInvestment
BioT Team
Employee Info
| Employees (range) | 11-50 |
| Exact count | 31 |
| Team members | 7 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 28 classification IDs that could be used for matching.
BioT Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 100/100 |
| Missing | markets |
| BI Verification | Yanina Wainscheinker |
| Registrar ID | 514756683 |
| Crunchbase | bio-t-medical |
| Phone | +972747024735 |
| Creator | Noa Zamir |
| Creator email | noa@softimize.co |
| Last updater | Matan Eblagon |
| Updater email | matane@sncentral.org |
| Last update | 2024-11-18T00:00:00.000Z |
| Created | 2018-12-09T00:00:00.000Z |
| Claimed | Yes |